• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mohs 显微外科手术后伤口并发症的发生率:英国教学医院 1000 例接受 Mohs 显微外科手术和伤口修复患者的横断面研究。

Prevalence of wound complications following Mohs micrographic surgery (MMS): a cross-sectional study of 1000 patients undergoing MMS and wound repair in a UK teaching hospital.

机构信息

Department of Dermatology, Northern Care Alliance NHS Foundation Trust, Manchester, UK.

Centre for Dermatology Research, The University of Manchester, Manchester, UK.

出版信息

Clin Exp Dermatol. 2022 Aug;47(8):1536-1542. doi: 10.1111/ced.15226. Epub 2022 May 25.

DOI:10.1111/ced.15226
PMID:35490302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9546076/
Abstract

BACKGROUND

Mohs micrographic surgery (MMS) for nonmelanoma skin cancer is often quoted as having an excellent safety profile.

AIM

To determine the complication rate of patients undergoing MMS in a large UK Mohs unit and subdivide complication rates into mild/intermediate and major, and to identify potential risk factors necessitating a clinical intervention.

METHODS

This was a single-centre, cross-sectional study of 1000 consecutive cases of MMS performed with in-house repair. Notes from the postsurgical dressing clinics were reviewed at Visit 1 (Days 7-14) and Visit 2 (approximately Week 6). Based upon the intervention required and effect on cosmetic/functional outcome, complications were classified as minor, intermediate or major. Logistic regression modelling was used to identify risk factors associated with a complication that needed a clinical intervention (i.e. intermediate or major).

RESULTS

In total, 1000 Mohs surgeries were performed on 803 patients, resulting in 1067 excisions. Complication rates in our cohort were low (minor 3.6%, intermediate 3.1% and major 0.8%) Potential risk factors for developing a complication included skin graft (unadjusted OR = 4.89, 95% CI 1.93-12.39; fully adjusted OR = 7.13, 95% CI 2.26-22.45) and patients undergoing surgery on the forehead (unadjusted OR = 3.32, 95% CI 0.95-11.58; fully adjusted OR = 5.34, 95% CI 1.40-20.42). Patients whose wounds were allowed to heal by secondary intention healing (6.8%) exhibited no complications.

CONCLUSION

We advocate that patients should be informed during the consent procedure that less than 1 in every 100 patients (0.75%) undergoing MMS will have a serious adverse event (major complication) affecting their cosmetic or functional outcome.

摘要

背景

Mohs 显微外科手术(MMS)治疗非黑色素瘤皮肤癌通常被认为具有极好的安全性。

目的

确定在英国一家大型 Mohs 单位接受 MMS 治疗的患者的并发症发生率,并将并发症发生率细分为轻度/中度和重度,并确定需要临床干预的潜在危险因素。

方法

这是一项在 1000 例连续 MMS 病例中进行的单中心、横断面研究,采用内部修复。在术后第 1 次就诊(第 7-14 天)和第 2 次就诊(大约第 6 周)时,对术后门诊就诊记录进行了回顾。根据需要的干预措施以及对美容/功能结果的影响,将并发症分为轻度、中度和重度。采用逻辑回归模型确定与需要临床干预(即中度或重度)的并发症相关的危险因素。

结果

共对 803 例患者的 1000 次 Mohs 手术进行了分析,共进行了 1067 次切除。本队列的并发症发生率较低(轻度 3.6%,中度 3.1%,重度 0.8%)。潜在的危险因素包括皮肤移植(未调整的 OR=4.89,95%CI 1.93-12.39;完全调整的 OR=7.13,95%CI 2.26-22.45)和在前额接受手术的患者(未调整的 OR=3.32,95%CI 0.95-11.58;完全调整的 OR=5.34,95%CI 1.40-20.42)。让伤口自然愈合(6.8%)的患者没有出现并发症。

结论

我们主张在手术知情同意过程中告知患者,不到每 100 例接受 MMS 治疗的患者中(0.75%)会发生影响其美容或功能结果的严重不良事件(重大并发症)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a25/9546076/5a033e4acc67/CED-47-1536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a25/9546076/5a033e4acc67/CED-47-1536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a25/9546076/5a033e4acc67/CED-47-1536-g001.jpg

相似文献

1
Prevalence of wound complications following Mohs micrographic surgery (MMS): a cross-sectional study of 1000 patients undergoing MMS and wound repair in a UK teaching hospital.Mohs 显微外科手术后伤口并发症的发生率:英国教学医院 1000 例接受 Mohs 显微外科手术和伤口修复患者的横断面研究。
Clin Exp Dermatol. 2022 Aug;47(8):1536-1542. doi: 10.1111/ced.15226. Epub 2022 May 25.
2
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.与Mohs 显微外科手术相关的不良事件:23 个中心 20821 例的多中心前瞻性队列研究。
JAMA Dermatol. 2013 Dec;149(12):1378-85. doi: 10.1001/jamadermatol.2013.6255.
3
A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery.对莫氏显微外科手术相关并发症发生率的前瞻性评估。
Arch Dermatol. 2003 Feb;139(2):143-52. doi: 10.1001/archderm.139.2.143.
4
Complications After Mohs Micrographic Surgery in Patients Aged 85 and Older.85 岁及以上患者行 Mohs 显微外科手术后的并发症。
Dermatol Surg. 2021 Feb 1;47(2):189-193. doi: 10.1097/DSS.0000000000002452.
5
Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.基底细胞癌的莫氏显微外科手术:一项西班牙回顾性研究结果及肿瘤复发的Kaplan-Meier生存分析
J Eur Acad Dermatol Venereol. 2014 Oct;28(10):1363-9. doi: 10.1111/jdv.12293.
6
Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics.不使用预防性抗生素的莫氏显微外科手术患者手术部位感染率的前瞻性评估。
J Am Acad Dermatol. 2008 Aug;59(2):275-8. doi: 10.1016/j.jaad.2008.03.042.
7
A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery.4 年回顾性评估免疫抑制患者行 Mohs 显微外科手术后的术后并发症。
J Am Acad Dermatol. 2019 Jun;80(6):1594-1601. doi: 10.1016/j.jaad.2018.11.032. Epub 2018 Nov 28.
8
Assessment of intraoperative pain during Mohs micrographic surgery (MMS): An opportunity for improved patient care.莫氏显微外科手术(MMS)术中疼痛评估:改善患者护理的契机。
J Am Acad Dermatol. 2016 Sep;75(3):590-594. doi: 10.1016/j.jaad.2016.02.1230. Epub 2016 Apr 25.
9
Online Readability Analysis: Mohs Micrographic Surgery Postsurgical Wound Care.在线易读性分析:Mohs 显微外科手术后伤口护理。
Adv Skin Wound Care. 2022 Apr 1;35(4):213-218. doi: 10.1097/01.ASW.0000816960.79821.e3.
10
Association of Mohs Reconstructive Surgery Timing With Postoperative Complications.Mohs 修复手术时机与术后并发症的关联。
JAMA Facial Plast Surg. 2018 Mar 1;20(2):122-127. doi: 10.1001/jamafacial.2017.1154.

引用本文的文献

1
Mohs Micrographic Surgery: A Narrative Review of Current Practices, Emerging Trends, and Case-Based Insights.莫氏显微外科手术:当前实践、新趋势及基于病例的见解的叙述性综述
Adv Ther. 2025 Sep 18. doi: 10.1007/s12325-025-03354-w.
2
Lines under the eyes: a large prospective case series of linear basal cell carcinomas.眼下细纹:一项关于线性基底细胞癌的大型前瞻性病例系列研究。
Arch Dermatol Res. 2023 Apr;315(3):621-624. doi: 10.1007/s00403-022-02385-5. Epub 2022 Aug 12.

本文引用的文献

1
Review and reappraisal of assessment parameters of second intention healing after Mohs micrographic surgery.莫氏显微外科手术后二期愈合评估参数的回顾与重新评估。
Arch Dermatol Res. 2022 Jan;314(1):17-23. doi: 10.1007/s00403-021-02209-y. Epub 2021 Feb 20.
2
Secondary Intention Healing After Mohs Surgical Excision as an Alternative to Surgical Repair: Evaluation of Wound Characteristics and Esthetic Outcomes.莫氏手术切除后二期愈合作为手术修复替代方案:伤口特征及美学效果评估
Ann Plast Surg. 2020 Jul;85(S1 Suppl 1):S28-S32. doi: 10.1097/SAP.0000000000002330.
3
Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
Mohs 显微外科手术治疗基底细胞癌与鳞状细胞癌的差异。
Int J Dermatol. 2018 Nov;57(11):1375-1381. doi: 10.1111/ijd.14223. Epub 2018 Sep 23.
4
Safety, complications and patients' acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group.局部麻醉下莫氏显微外科手术的安全性、并发症及患者接受度:英国莫氏手术接受度与患者安全(MAPS)协作组的研究结果
Br J Dermatol. 2017 Mar;176(3):806-808. doi: 10.1111/bjd.14843. Epub 2017 Feb 22.
5
The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital.在巴西一家大学医院对139例行莫氏显微描记手术患者的回顾性研究中浅表性基底细胞癌的重要性。
Clinics (Sao Paulo). 2015 Nov;70(11):721-5. doi: 10.6061/clinics/2015(11)01.
6
Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.非黑色素瘤皮肤癌治疗共识:基底细胞癌,包括治疗方法的成本分析。
Dermatol Surg. 2015 May;41(5):550-71. doi: 10.1097/DSS.0000000000000296.
7
Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.面部基底细胞癌的手术切除与 Mohs 显微外科手术:一项 10 年随访的随机临床试验。
Eur J Cancer. 2014 Nov;50(17):3011-20. doi: 10.1016/j.ejca.2014.08.018. Epub 2014 Sep 25.
8
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.与Mohs 显微外科手术相关的不良事件:23 个中心 20821 例的多中心前瞻性队列研究。
JAMA Dermatol. 2013 Dec;149(12):1378-85. doi: 10.1001/jamadermatol.2013.6255.
9
The future of technologies for personalised medicine.个性化医疗技术的未来。
N Biotechnol. 2012 Sep 15;29(6):625-33. doi: 10.1016/j.nbt.2012.03.009.
10
The safety of Mohs surgery: a prospective multicenter cohort study.Mohs 手术的安全性:一项前瞻性多中心队列研究。
J Am Acad Dermatol. 2012 Dec;67(6):1302-9. doi: 10.1016/j.jaad.2012.05.041. Epub 2012 Aug 11.